Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Ultragenyx Pharmaceu (NQ: RARE )

45.73 -1.61 (-3.40%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 378,549
Open 46.66
Bid (Size) 44.00 (20)
Ask (Size) 73.71 (2)
Prev. Close 47.34
Today's Range 45.66 - 47.41
52wk Range 33.36 - 85.53
Shares Outstanding 70,105,654
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Analyst Expectations for Ultragenyx Pharmaceutical's Future
 
Via Benzinga
Ultragenyx Reports Preliminary 2022 Revenue; Guidance for 2023 Revenue and Cash Usage; Pipeline Updates and 2023 Milestones
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire

Performance

YTD
+0.46%
+0.46%
1 Month
-3.60%
-3.60%
3 Month
+29.66%
+29.66%
6 Month
-17.75%
-17.75%
1 Year
-32.36%
-32.36%

More News

Read More
Ultragenyx to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
What You Missed On Wall Street On Friday
Via Talk Markets
The Latest Analyst Ratings for Ultragenyx Pharmaceutical
Via Benzinga
Analyst Expectations for Ultragenyx Pharmaceutical's Future
Via Benzinga
Where Ultragenyx Pharmaceutical Stands With Analysts
Via Benzinga
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Ultragenyx to Present at Piper Sandler Healthcare Conference
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Ultragenyx Announces Departure of Chief Financial Officer
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Ultragenyx to Present at Upcoming Healthcare Conferences
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Benzinga's Top Ratings Upgrades, Downgrades For November 3, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
Ultragenyx Reports Third Quarter 2022 Financial Results and Corporate Update
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
9 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Ultragenyx to Host Conference Call for Third Quarter 2022 Financial Results and Corporate Update
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
From Ultragenyx Pharmaceutical Inc.
Via Globe NewsWire
Earnings Scheduled For November 2, 2022
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
Via Benzinga
This Healthcare Stock Is Trading Lower By 29%: Here Are 29 Stocks Moving Premarket
Via Benzinga
Cisco, Keysight Technologies And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
Via Benzinga
NVIDIA, Tyson Foods, BioNTech And Some Other Big Stocks Moving Lower On Monday
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.